Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on Linomide.

Rowe, J M

Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on Linomide. [electronic resource] - Leukemia & lymphoma Nov 1993 - 321-9 p. digital

Publication Type: Journal Article; Review

1042-8194

10.3109/10428199309067922 doi


Adjuvants, Immunologic--therapeutic use
Humans
Hydroxyquinolines--therapeutic use
Immunotherapy
Interferons--therapeutic use
Interleukin-2--therapeutic use
Killer Cells, Natural--immunology
Leukemia, Myeloid--drug therapy
T-Lymphocytes--immunology